XXX - Imaging features
Imaging: A miliary pattern (diffuse random micronodules)
Last update 17/06/2026
XXX - Imaging features
Last update 17/06/2026
XIV. Pleural involvement
XIV.a Pleural effusion (uni or bilateral) (can accompany ILD induced by the drug)
XX. Vasculitis
XX.c Vascultis (pulmonary, extrathoracic or systemic) - ANCA status unknown or negative
XXI. Mediastinal involvement/injury
XXI.a Lymphadenopathy (intrathoracic)
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.a Pneumonitis (ILD)
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.b Pneumonitis (ILD), acute and/or severe (may cause ARDS)
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.f Diffuse alveolar damage (DAD) imaging pattern
XXIX. Small airway involvement
XXIX.d Cough (lone)
XXX. Imaging features
XXX.b Imaging: A miliary pattern (diffuse random micronodules)
XXX. Imaging features
XXX.n Imaging: A 'tree-in-bud' pattern
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.h Myasthenia gravis - Myasthenic-like syndrome
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.i Guillain-Barré (or GB-like) syndrome (w/wo ARF)
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.k Multiple organ dysfunction/failure (MODS/MOF)
XXXVIII. Miscellaneous - Varia
XXXVIII.a Upper airway obstruction other than angioedema or hematoma
XXXVIII. Miscellaneous - Varia
XXXVIII.k Hypersensitivity reaction (may manifest with fever and/or skin, throat or airway involvement)